메뉴 건너뛰기




Volumn , Issue , 2011, Pages 285-298

Replication-defective herpes simplex virus mutant strains as genital herpes vaccines and vaccine vectors

Author keywords

[No Author keywords available]

Indexed keywords

HERPES SIMPLEX VACCINE; HERPEVAC; HERPEVAC VACCINE; IMMUNOVEX; IMMUNOVEX VACCINE; UNCLASSIFIED DRUG;

EID: 79960030795     PISSN: None     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-3-0346-0277-8_12     Document Type: Review
Times cited : (1)

References (68)
  • 1
    • 34249950342 scopus 로고    scopus 로고
    • Herpes simplex virus
    • In: Knipe DM, Howley PM, 5th ed. Lippincott, Williams and Wilkins, Philadelphia, PA
    • Roizman B, Knipe DM, Whitley RJ (2007) Herpes simplex virus. In: Knipe DM, Howley PM (eds) Fields Virology, 5th ed. Lippincott, Williams and Wilkins, Philadelphia, PA, pp 2501-2602
    • (2007) Fields Virology , pp. 2501-2602
    • Roizman, B.1    Knipe, D.M.2    Whitley, R.J.3
  • 2
    • 29144444035 scopus 로고    scopus 로고
    • Herpes simplex virus 2 infection increases HIV acquisition in men and women: Systematic review and metaanalysis of longitudinal studies
    • Freeman EE, Weiss HA, Glynn JR, Cross PL, Whitworth JA, Hayes RJ (2006) Herpes simplex virus 2 infection increases HIV acquisition in men and women: systematic review and metaanalysis of longitudinal studies. AIDS 20:73-83
    • (2006) AIDS , vol.20 , pp. 73-83
    • Freeman, E.E.1    Weiss, H.A.2    Glynn, J.R.3    Cross, P.L.4    Whitworth, J.A.5    Hayes, R.J.6
  • 3
    • 0036137322 scopus 로고    scopus 로고
    • Risk of human immunodeficiency virus infection in herpes simplex virus type 2-seropositive persons: A meta-analysis
    • Wald A, Link K (2002) Risk of human immunodeficiency virus infection in herpes simplex virus type 2-seropositive persons: a meta-analysis. J Infect Dis 185:45-52
    • (2002) J Infect Dis , vol.185 , pp. 45-52
    • Wald, A.1    Link, K.2
  • 5
    • 56749131188 scopus 로고    scopus 로고
    • Herpes simplex virus (HSV)-suppressive therapy decreases plasma and genital HIV-1 levels in HSV-2/HIV-1 coinfected women: A randomized, placebocontrolled, cross-over trial
    • Baeten JM, Strick LB, Lucchetti A, Whittington WL, Sanchez J, Coombs RW, Magaret A, Wald A, Corey L, Celum C (2008) Herpes simplex virus (HSV)-suppressive therapy decreases plasma and genital HIV-1 levels in HSV-2/HIV-1 coinfected women: a randomized, placebocontrolled, cross-over trial. J Infect Dis 198:1804-1808
    • (2008) J Infect Dis , vol.198 , pp. 1804-1808
    • Baeten, J.M.1    Strick, L.B.2    Lucchetti, A.3    Whittington, W.L.4    Sanchez, J.5    Coombs, R.W.6    Magaret, A.7    Wald, A.8    Corey, L.9    Celum, C.10
  • 6
    • 45249108765 scopus 로고    scopus 로고
    • Effect of aciclovir on HIV-1 acquisition in herpes simplex virus 2 seropositive women and men who have sex with men: A randomised, double-blind, placebocontrolled trial
    • Celum C, Wald A, Hughes J, Sanchez J, Reid S, Delany-Moretlwe S, Cowan F, Casapia M, Ortiz A, Fuchs J et al (2008) Effect of aciclovir on HIV-1 acquisition in herpes simplex virus 2 seropositive women and men who have sex with men: a randomised, double-blind, placebocontrolled trial. Lancet 371:2109-2119
    • (2008) Lancet , vol.371 , pp. 2109-2119
    • Celum, C.1    Wald, A.2    Hughes, J.3    Sanchez, J.4    Reid, S.5    Delany-Moretlwe, S.6    Cowan, F.7    Casapia, M.8    Ortiz, A.9    Fuchs, J.10
  • 8
    • 0029015680 scopus 로고
    • Herpes simplex virus vaccines as immunotherapeutic agents
    • Stanberry LR (1995) Herpes simplex virus vaccines as immunotherapeutic agents. Trends Microbiol 3:244-247
    • (1995) Trends Microbiol , vol.3 , pp. 244-247
    • Stanberry, L.R.1
  • 9
    • 0027828892 scopus 로고
    • Prospects for vaccination against herpes simplex virus
    • Whitley RJ (1993) Prospects for vaccination against herpes simplex virus. Pediatr Ann 22:726-732
    • (1993) Pediatr Ann , vol.22 , pp. 726-732
    • Whitley, R.J.1
  • 10
    • 0033537972 scopus 로고    scopus 로고
    • Vaccine potential of a herpes simplex virus type 2 mutant deleted in the PK domain of the large subunit of ribonucleotide reductase (ICP10)
    • Aurelian L, Kokuba H, Smith CC (1999) Vaccine potential of a herpes simplex virus type 2 mutant deleted in the PK domain of the large subunit of ribonucleotide reductase (ICP10). Vaccine 17:1951-1963
    • (1999) Vaccine , vol.17 , pp. 1951-1963
    • Aurelian, L.1    Kokuba, H.2    Smith, C.C.3
  • 11
    • 0035961451 scopus 로고    scopus 로고
    • A growth and latency compromised herpes simplex virus type 2 mutant (ICP10DeltaPK) has prophylactic and therapeutic protective activity in guinea pigs
    • Wachsman M, Kulka M, Smith CC, Aurelian L (2001) A growth and latency compromised herpes simplex virus type 2 mutant (ICP10DeltaPK) has prophylactic and therapeutic protective activity in guinea pigs. Vaccine 19:1879-1890
    • (2001) Vaccine , vol.19 , pp. 1879-1890
    • Wachsman, M.1    Kulka, M.2    Smith, C.C.3    Aurelian, L.4
  • 13
    • 50149109604 scopus 로고    scopus 로고
    • A replication-competent, neuronal spread-defective, live attenuated herpes simplex virus type 1 vaccine
    • Brittle EE, Wang F, Lubinski JM, Bunte RM, Friedman HM (2008) A replication-competent, neuronal spread-defective, live attenuated herpes simplex virus type 1 vaccine. J Virol 82:8431-8441
    • (2008) J Virol , vol.82 , pp. 8431-8441
    • Brittle, E.E.1    Wang, F.2    Lubinski, J.M.3    Bunte, R.M.4    Friedman, H.M.5
  • 15
  • 16
    • 16944362192 scopus 로고    scopus 로고
    • Immunotherapy of recurrent genital herpes with recombinant herpes simplex virus type 2 glycoproteins D and B: Results of a placebocontrolled vaccine trial
    • Straus SE, Wald A, Kost RG et al (1997) Immunotherapy of recurrent genital herpes with recombinant herpes simplex virus type 2 glycoproteins D and B: results of a placebocontrolled vaccine trial. J Infect Dis 176:1129-1134
    • (1997) J Infect Dis , vol.176 , pp. 1129-1134
    • Straus, S.E.1    Wald, A.2    Kost, R.G.3
  • 18
    • 0037237569 scopus 로고    scopus 로고
    • Recent progress in herpes simplex virus immunobiology and vaccine research
    • Koelle DM, Corey L (2003) Recent progress in herpes simplex virus immunobiology and vaccine research. Clin Microbiol Rev 16:96-113
    • (2003) Clin Microbiol Rev , vol.16 , pp. 96-113
    • Koelle, D.M.1    Corey, L.2
  • 19
    • 0026447939 scopus 로고
    • Replication-defective mutants of herpes simplex virus (HSV) induce cellular immunity and protect against lethal HSV infection
    • Nguyen LH, Knipe DM, Finberg RW (1992) Replication-defective mutants of herpes simplex virus (HSV) induce cellular immunity and protect against lethal HSV infection. J Virol 66: 7067-7072
    • (1992) J Virol , vol.66 , pp. 7067-7072
    • Nguyen, L.H.1    Knipe, D.M.2    Finberg, R.W.3
  • 20
    • 0030917882 scopus 로고    scopus 로고
    • Construction and characterization of a replication-defective herpes simplex virus 2 ICP8 mutant strain and its use in immunization studies in a guinea pig model of genital herpes
    • Da Costa XJ, Bourne N, Stanberry LR, Knipe DM (1997) Construction and characterization of a replication-defective herpes simplex virus 2 ICP8 mutant strain and its use in immunization studies in a guinea pig model of genital herpes. Virology 232:1-12
    • (1997) Virology , vol.232 , pp. 1-12
    • da Costa, X.J.1    Bourne, N.2    Stanberry, L.R.3    Knipe, D.M.4
  • 21
    • 0022343688 scopus 로고
    • Identification of a herpes simplex virus function that represses late gene expression from parental viral genomes
    • Godowski PJ, Knipe DM (1985) Identification of a herpes simplex virus function that represses late gene expression from parental viral genomes. J Virol 55:357-365
    • (1985) J Virol , vol.55 , pp. 357-365
    • Godowski, P.J.1    Knipe, D.M.2
  • 22
    • 0033536011 scopus 로고    scopus 로고
    • Immunization against genital herpes with a vaccine virus that has defects in productive and latent infection
    • Da Costa XJ, Jones CA, Knipe DM (1999) Immunization against genital herpes with a vaccine virus that has defects in productive and latent infection. Proc Natl Acad Sci USA 96: 6994-6998
    • (1999) Proc Natl Acad Sci USA , vol.96 , pp. 6994-6998
    • da Costa, X.J.1    Jones, C.A.2    Knipe, D.M.3
  • 23
    • 0033882023 scopus 로고    scopus 로고
    • Construction, phenotypic analysis, and immunogenicity of a UL5/UL29 double deletion mutant of herpes simplex virus 2
    • Da Costa XJ, Kramer MF, Zhu J, Brockman MA, Knipe DM (2000) Construction, phenotypic analysis, and immunogenicity of a UL5/UL29 double deletion mutant of herpes simplex virus 2. J Virol 74:7963-7971
    • (2000) J Virol , vol.74 , pp. 7963-7971
    • da Costa, X.J.1    Kramer, M.F.2    Zhu, J.3    Brockman, M.A.4    Knipe, D.M.5
  • 24
    • 10644231702 scopus 로고    scopus 로고
    • Comparative efficacy and immunogenicity of replication-defective, recombinant glycoprotein, and DNA vaccines for herpes simplex virus 2 infections in mice and guinea pigs
    • Hoshino Y, Dalai SK, Wang K, Pesnicak L, Lau TY, Knipe DM, Cohen JI, Straus SE (2005) Comparative efficacy and immunogenicity of replication-defective, recombinant glycoprotein, and DNA vaccines for herpes simplex virus 2 infections in mice and guinea pigs. J Virol 79:410-418
    • (2005) J Virol , vol.79 , pp. 410-418
    • Hoshino, Y.1    Dalai, S.K.2    Wang, K.3    Pesnicak, L.4    Lau, T.Y.5    Knipe, D.M.6    Cohen, J.I.7    Straus, S.E.8
  • 25
    • 0028047306 scopus 로고
    • Immunization with replication-defective mutants of herpes simplex virus type 1: Sites of immune intervention in pathogenesis of challenge virus infection
    • Morrison LA, Knipe DM (1994) Immunization with replication-defective mutants of herpes simplex virus type 1: Sites of immune intervention in pathogenesis of challenge virus infection. J Virol 68:689-696
    • (1994) J Virol , vol.68 , pp. 689-696
    • Morrison, L.A.1    Knipe, D.M.2
  • 26
    • 38949207545 scopus 로고    scopus 로고
    • Disruption of the U(L)41 gene in the herpes simplex virus 2 dl5-29 mutant increases its immunogenicity and protective capacity in a murine model of genital herpes
    • Dudek T, Mathews LC, Knipe DM (2008) Disruption of the U(L)41 gene in the herpes simplex virus 2 dl5-29 mutant increases its immunogenicity and protective capacity in a murine model of genital herpes. Virology 372:165-175
    • (2008) Virology , vol.372 , pp. 165-175
    • Dudek, T.1    Mathews, L.C.2    Knipe, D.M.3
  • 27
    • 0013931405 scopus 로고
    • Longevity and gross pathology at death in 22 inbred strains of mice
    • Storer JB (1966) Longevity and gross pathology at death in 22 inbred strains of mice. J Gerontol 21:404-409
    • (1966) J Gerontol , vol.21 , pp. 404-409
    • Storer, J.B.1
  • 28
    • 33745770407 scopus 로고    scopus 로고
    • Optimal long-term humoral responses to replication-defective herpes simplex virus require CD21/CD35 complement receptor expression on stromal cells
    • Brockman MA, Verschoor A, Zhu J, Carroll MC, Knipe DM (2006) Optimal long-term humoral responses to replication-defective herpes simplex virus require CD21/CD35 complement receptor expression on stromal cells. J Virol 80:7111-7117
    • (2006) J Virol , vol.80 , pp. 7111-7117
    • Brockman, M.A.1    Verschoor, A.2    Zhu, J.3    Carroll, M.C.4    Knipe, D.M.5
  • 29
    • 43749114944 scopus 로고    scopus 로고
    • Replication-defective virus vaccine-induced protection of mice from genital herpes simplex virus 2 requires CD4 T cells
    • Morrison LA (2008) Replication-defective virus vaccine-induced protection of mice from genital herpes simplex virus 2 requires CD4 T cells. Virology 376:205-210
    • (2008) Virology , vol.376 , pp. 205-210
    • Morrison, L.A.1
  • 30
    • 47149104462 scopus 로고    scopus 로고
    • Comparison of immunogenicity and protective efficacy of genital herpes vaccine candidates herpes simplex virus 2 dl5-29 and dl5-29-41L in mice and guinea pigs
    • Hoshino Y, Pesnicak L, Dowdell KC, Lacayo J, Dudek T, Knipe DM, Straus SE, Cohen JI (2008) Comparison of immunogenicity and protective efficacy of genital herpes vaccine candidates herpes simplex virus 2 dl5-29 and dl5-29-41L in mice and guinea pigs. Vaccine 26:4034-4040
    • (2008) Vaccine , vol.26 , pp. 4034-4040
    • Hoshino, Y.1    Pesnicak, L.2    Dowdell, K.C.3    Lacayo, J.4    Dudek, T.5    Knipe, D.M.6    Straus, S.E.7    Cohen, J.I.8
  • 31
    • 70349348947 scopus 로고    scopus 로고
    • Protection from herpes simplex virus (HSV)-2 infection with replication-defective HSV-2 or glycoprotein D2 vaccines in HSV-1-seropositive and HSV-1-seronegative guinea pigs
    • Hoshino Y, Pesnicak L, Dowdell KC, Burbelo PD, Knipe DM, Straus SE, Cohen JI (2009) Protection from herpes simplex virus (HSV)-2 infection with replication-defective HSV-2 or glycoprotein D2 vaccines in HSV-1-seropositive and HSV-1-seronegative guinea pigs. J Infect Dis 200:1088-1095
    • (2009) J Infect Dis , vol.200 , pp. 1088-1095
    • Hoshino, Y.1    Pesnicak, L.2    Dowdell, K.C.3    Burbelo, P.D.4    Knipe, D.M.5    Straus, S.E.6    Cohen, J.I.7
  • 32
    • 0032579775 scopus 로고    scopus 로고
    • Influence of mucosal and parenteral immunization with a replication-defective mutant of HSV-2 on immune responses and protection from genital challenge
    • Morrison LA, Da Costa XJ, Knipe DM (1998) Influence of mucosal and parenteral immunization with a replication-defective mutant of HSV-2 on immune responses and protection from genital challenge. Virology 243:178-187
    • (1998) Virology , vol.243 , pp. 178-187
    • Morrison, L.A.1    da Costa, X.J.2    Knipe, D.M.3
  • 33
    • 1942435283 scopus 로고    scopus 로고
    • Epidemiology of genital herpes simplex virus infection in developed countries
    • Malkin JE (2004) Epidemiology of genital herpes simplex virus infection in developed countries. Herpes 11(Suppl 1):2A-23A
    • (2004) Herpes , vol.11 , Issue.SUPPL. 1
    • Malkin, J.E.1
  • 35
    • 35549008771 scopus 로고    scopus 로고
    • Immunization with a replication-defective herpes simplex virus 2 mutant reduces herpes simplex virus 1 infection and prevents ocular disease
    • van Lint AL, Torres-Lopez E, Knipe DM (2007) Immunization with a replication-defective herpes simplex virus 2 mutant reduces herpes simplex virus 1 infection and prevents ocular disease. Virology 368:227-231
    • (2007) Virology , vol.368 , pp. 227-231
    • van Lint, A.L.1    Torres-Lopez, E.2    Knipe, D.M.3
  • 36
    • 0026556674 scopus 로고
    • Construction and properties of a mutant of herpes simplex virus type 1 with glycoprotein H coding sequences deleted
    • Forrester A, Farrell H, Wilkinson G, Kaye J, Davis-Poynter N, Minson T (1992) Construction and properties of a mutant of herpes simplex virus type 1 with glycoprotein H coding sequences deleted. J Virol 66:341-348
    • (1992) J Virol , vol.66 , pp. 341-348
    • Forrester, A.1    Farrell, H.2    Wilkinson, G.3    Kaye, J.4    Davis-Poynter, N.5    Minson, T.6
  • 37
    • 0028039848 scopus 로고
    • Vaccine potential of a herpes simplex virus type 1 mutant with an essential glycoprotein deleted
    • Farrell HE, McLean CS, Efstathlou S, Inglls S, Minson AC (1994) Vaccine potential of a herpes simplex virus type 1 mutant with an essential glycoprotein deleted. J Virol 68: 927-932
    • (1994) J Virol , vol.68 , pp. 927-932
    • Farrell, H.E.1    McLean, C.S.2    Efstathlou, S.3    Inglls, S.4    Minson, A.C.5
  • 38
    • 0028020595 scopus 로고
    • Protective vaccination against primary and recurrent disease caused by herpes simplex virus (HSV) type 2 using a geneitcally disabled HSV-1
    • McLean CS, Erturk M, Jennings R, Challanain DN, Minson AC, Duncan I, Boursnell ME, Inglis SC (1994) Protective vaccination against primary and recurrent disease caused by herpes simplex virus (HSV) type 2 using a geneitcally disabled HSV-1. J Infect Dis 170:1100-1109
    • (1994) J Infect Dis , vol.170 , pp. 1100-1109
    • McLean, C.S.1    Erturk, M.2    Jennings, R.3    Challanain, D.N.4    Minson, A.C.5    Duncan, I.6    Boursnell, M.E.7    Inglis, S.C.8
  • 40
    • 31844455180 scopus 로고    scopus 로고
    • A randomized controlled trial of a replication defective (gH deletion) herpes simplex virus vaccine for the treatment of recurrent genital herpes among immunocompetent subjects
    • de Bruyn G, Vargas-Cortez M, Warren T, Tyring SK, Fife KH, Lalezari J, Brady RC, Shahmanesh M, Kinghorn G, Beutner KR et al (2006) A randomized controlled trial of a replication defective (gH deletion) herpes simplex virus vaccine for the treatment of recurrent genital herpes among immunocompetent subjects. Vaccine 24:914-920
    • (2006) Vaccine , vol.24 , pp. 914-920
    • de Bruyn, G.1    Vargas-Cortez, M.2    Warren, T.3    Tyring, S.K.4    Fife, K.H.5    Lalezari, J.6    Brady, R.C.7    Shahmanesh, M.8    Kinghorn, G.9    Beutner, K.R.10
  • 41
    • 0028283971 scopus 로고
    • Acytosolic herpes simplex virus protein inhibits antigen presentation to CD8+ T lymphocytes
    • York IA, Roop C, Andrews DW, Riddell SR, Graham FL, Johnson DC (1994) Acytosolic herpes simplex virus protein inhibits antigen presentation to CD8+ T lymphocytes. Cell 77:525-535
    • (1994) Cell , vol.77 , pp. 525-535
    • York, I.A.1    Roop, C.2    Andrews, D.W.3    Riddell, S.R.4    Graham, F.L.5    Johnson, D.C.6
  • 42
    • 0020526685 scopus 로고
    • Herpes simplex virus mutants defective in the virion-associated shutoff of host polypeptide synthesis and exhibiting abnormal synthesis of alpha (immediate early) viral polypeptides
    • Read GS, Frenkel N (1983) Herpes simplex virus mutants defective in the virion-associated shutoff of host polypeptide synthesis and exhibiting abnormal synthesis of alpha (immediate early) viral polypeptides. J Virol 46:498-512
    • (1983) J Virol , vol.46 , pp. 498-512
    • Read, G.S.1    Frenkel, N.2
  • 43
    • 33748511878 scopus 로고    scopus 로고
    • The virion host shutoff protein (UL41) of herpes simplex virus 1 is an endoribonuclease with a substrate specificity similar to that of RNase A
    • Taddeo B, Roizman B (2006) The virion host shutoff protein (UL41) of herpes simplex virus 1 is an endoribonuclease with a substrate specificity similar to that of RNase A. J Virol 80: 9341-9345
    • (2006) J Virol , vol.80 , pp. 9341-9345
    • Taddeo, B.1    Roizman, B.2
  • 44
    • 0031017382 scopus 로고    scopus 로고
    • The gamma (1)34.5 protein of herpes simplex virus 1 complexes with protein phosphatase 1 alpha to dephosphorylate the alpha subunit of the eukaryotic translation initiation factor 2 and preclude the shutoff of protein synthesis by double-stranded RNA-activated protein kinase
    • He B, Gross M, Roizman B (1997) The gamma (1)34.5 protein of herpes simplex virus 1 complexes with protein phosphatase 1 alpha to dephosphorylate the alpha subunit of the eukaryotic translation initiation factor 2 and preclude the shutoff of protein synthesis by double-stranded RNA-activated protein kinase. Proc Natl Acad Sci USA 94:843-848
    • (1997) Proc Natl Acad Sci USA , vol.94 , pp. 843-848
    • He, B.1    Gross, M.2    Roizman, B.3
  • 45
    • 3543054546 scopus 로고    scopus 로고
    • Herpes simplex virus 1 has multiple mechanisms for blocking virus-induced interferon production
    • Melroe G, DeLuca N, Knipe DM (2004) Herpes simplex virus 1 has multiple mechanisms for blocking virus-induced interferon production. J Virol 78:8411-8420
    • (2004) J Virol , vol.78 , pp. 8411-8420
    • Melroe, G.1    Deluca, N.2    Knipe, D.M.3
  • 46
    • 43249125588 scopus 로고    scopus 로고
    • Expression of gamma interferon-dependent genes is blocked independently by virion host shutoff RNase and by US3 protein kinase
    • Liang L, Roizman B (2008) Expression of gamma interferon-dependent genes is blocked independently by virion host shutoff RNase and by US3 protein kinase. J Virol 82:4688-4696
    • (2008) J Virol , vol.82 , pp. 4688-4696
    • Liang, L.1    Roizman, B.2
  • 47
    • 76049126411 scopus 로고    scopus 로고
    • Simian TRIM5a proteins reduce replication of herpes simplex virus
    • Reszka NJ, Zhou C, Song B, Sodroski JG, Knipe DM (2010) Simian TRIM5a proteins reduce replication of herpes simplex virus. Virology 398:243-250
    • (2010) Virology , vol.398 , pp. 243-250
    • Reszka, N.J.1    Zhou, C.2    Song, B.3    Sodroski, J.G.4    Knipe, D.M.5
  • 48
    • 0031986439 scopus 로고    scopus 로고
    • Protection from primary infection and establishment of latency by vaccination with a herpes simplex virus type 1 recombinant deficient in the virion host shutoff (vhs) function
    • Walker J, Leib DA (1998) Protection from primary infection and establishment of latency by vaccination with a herpes simplex virus type 1 recombinant deficient in the virion host shutoff (vhs) function. Vaccine 16:1-5
    • (1998) Vaccine , vol.16 , pp. 1-5
    • Walker, J.1    Leib, D.A.2
  • 49
    • 0034469404 scopus 로고    scopus 로고
    • Disruption of virion host shutoff activity improves the immunogenicity and protective capacity of a replication-incompetent herpes simplex virus type 1 vaccine strain
    • Geiss BJ, Smith TJ, Leib DA, Morrison LA (2000) Disruption of virion host shutoff activity improves the immunogenicity and protective capacity of a replication-incompetent herpes simplex virus type 1 vaccine strain. J Virol 74:11137-11144
    • (2000) J Virol , vol.74 , pp. 11137-11144
    • Geiss, B.J.1    Smith, T.J.2    Leib, D.A.3    Morrison, L.A.4
  • 50
    • 77649231557 scopus 로고    scopus 로고
    • Construction and properties of a herpes simplex virus 2 dl5-29 vaccine candidate strain encoding an HSV-1 virion host shutoff protein
    • Reszka NJ, Dudek T, Knipe DM (2010) Construction and properties of a herpes simplex virus 2 dl5-29 vaccine candidate strain encoding an HSV-1 virion host shutoff protein. Vaccine 28(15): 2754-62
    • (2010) Vaccine , vol.28 , Issue.15 , pp. 2754-2762
    • Reszka, N.J.1    Dudek, T.2    Knipe, D.M.3
  • 51
    • 58149526764 scopus 로고    scopus 로고
    • Virus-encoded B7-2 costimulation molecules enhance the protective capacity of a replication-defective HSV-2 vaccine in immunocompetent mice
    • Vagvala SP, Thebeau LG, Wilson SR, Morrison LA (2009) Virus-encoded B7-2 costimulation molecules enhance the protective capacity of a replication-defective HSV-2 vaccine in immunocompetent mice. J Virol 83:953-960
    • (2009) J Virol , vol.83 , pp. 953-960
    • Vagvala, S.P.1    Thebeau, L.G.2    Wilson, S.R.3    Morrison, L.A.4
  • 52
    • 0029682760 scopus 로고    scopus 로고
    • Trends in HIV-1 and HIV-2 prevalence and risk factors in pregnant women in Harare, Zimbabwe
    • Mbizvo MT, Mashu A, Chipato T, Makura E, Bopoto R, Fottrell PF (1996) Trends in HIV-1 and HIV-2 prevalence and risk factors in pregnant women in Harare, Zimbabwe. Cent Afr J Med 42:14-21
    • (1996) Cent Afr J Med , vol.42 , pp. 14-21
    • Mbizvo, M.T.1    Mashu, A.2    Chipato, T.3    Makura, E.4    Bopoto, R.5    Fottrell, P.F.6
  • 54
    • 0033972358 scopus 로고    scopus 로고
    • Cervical shedding of herpes simplex virus in human immunodeficiency virus-infected women: Effects of hormonal contraception, pregnancy, and vitamin A deficiency
    • Mostad SB, Kreiss JK, Ryncarz AJ, Mandaliya K, Chohan B, Ndinya-Achola J, Bwayo JJ, Corey L (2000) Cervical shedding of herpes simplex virus in human immunodeficiency virus-infected women: effects of hormonal contraception, pregnancy, and vitamin A deficiency. J Infect Dis 181:58-63
    • (2000) J Infect Dis , vol.181 , pp. 58-63
    • Mostad, S.B.1    Kreiss, J.K.2    Ryncarz, A.J.3    Mandaliya, K.4    Chohan, B.5    Ndinya-Achola, J.6    Bwayo, J.J.7    Corey, L.8
  • 55
    • 36448938713 scopus 로고    scopus 로고
    • Divergence and recombination of clinical herpes simplex virus type 2 isolates
    • Norberg P, Kasubi MJ, Haarr L, Bergstrom T, Liljeqvist JA (2007) Divergence and recombination of clinical herpes simplex virus type 2 isolates. J Virol 81:13158-13167
    • (2007) J Virol , vol.81 , pp. 13158-13167
    • Norberg, P.1    Kasubi, M.J.2    Haarr, L.3    Bergstrom, T.4    Liljeqvist, J.A.5
  • 56
    • 0018194972 scopus 로고
    • Molecular genetics of herpes simplex virus: Demonstration of regions of obligatory and nonobligatory identity within diploid regions of the genome by sequence replacement and insertion
    • Knipe DM, Ruyechan WT, Roizman B, Halliburton IW (1978) Molecular genetics of herpes simplex virus: demonstration of regions of obligatory and nonobligatory identity within diploid regions of the genome by sequence replacement and insertion. Proc Natl Acad Sci USA 75:3896-3900
    • (1978) Proc Natl Acad Sci USA , vol.75 , pp. 3896-3900
    • Knipe, D.M.1    Ruyechan, W.T.2    Roizman, B.3    Halliburton, I.W.4
  • 57
    • 0030586549 scopus 로고    scopus 로고
    • Th1-associated immune responses to beta-galactosidase expressed by replication-defective herpes simplex virus
    • Brubaker JO, Thompson CM, Morrison LA, Knipe DM, Siber GB, Finberg RW (1996) Th1-associated immune responses to beta-galactosidase expressed by replication-defective herpes simplex virus. J Immunol 157:1598-1604
    • (1996) J Immunol , vol.157 , pp. 1598-1604
    • Brubaker, J.O.1    Thompson, C.M.2    Morrison, L.A.3    Knipe, D.M.4    Siber, G.B.5    Finberg, R.W.6
  • 60
    • 33751399952 scopus 로고    scopus 로고
    • Ability of herpes simplex virus vectors to boost immune responses to DNA vectors and to protect against challenge by simian immunodeficiency virus
    • Kaur A, Sanford HB, Garry D, Lang S, Klumpp SA, Watanabe D, Bronson RT, Lifson JD, Rosati M, Pavlakis GN et al (2007) Ability of herpes simplex virus vectors to boost immune responses to DNA vectors and to protect against challenge by simian immunodeficiency virus. Virology 357:199-214
    • (2007) Virology , vol.357 , pp. 199-214
    • Kaur, A.1    Sanford, H.B.2    Garry, D.3    Lang, S.4    Klumpp, S.A.5    Watanabe, D.6    Bronson, R.T.7    Lifson, J.D.8    Rosati, M.9    Pavlakis, G.N.10
  • 61
    • 64449086663 scopus 로고    scopus 로고
    • Genetic engineering of a modified herpes simplex virus 1 vaccine vector
    • Liu X, Broberg E, Watanabe D, Dudek T, DeLuca N, Knipe DM (2009) Genetic engineering of a modified herpes simplex virus 1 vaccine vector. Vaccine 27:2760-2767
    • (2009) Vaccine , vol.27 , pp. 2760-2767
    • Liu, X.1    Broberg, E.2    Watanabe, D.3    Dudek, T.4    Deluca, N.5    Knipe, D.M.6
  • 62
    • 0020451027 scopus 로고
    • The herpes simplex virus amplicon: A new eucaryotic defectivevirus cloning-amplifying vector
    • Spaete RR, Frenkel N (1982) The herpes simplex virus amplicon: a new eucaryotic defectivevirus cloning-amplifying vector. Cell 30:295-304
    • (1982) Cell , vol.30 , pp. 295-304
    • Spaete, R.R.1    Frenkel, N.2
  • 63
    • 0029844849 scopus 로고    scopus 로고
    • Helper virus-free transfer of herpes simplex virus type 1 plasmid vectors into neural cells
    • Fraefel C, Song S, Lim F, Lang P, Yu L, Wang Y, Wild P, Geller AI (1996) Helper virus-free transfer of herpes simplex virus type 1 plasmid vectors into neural cells. J Virol 70:7190-7197
    • (1996) J Virol , vol.70 , pp. 7190-7197
    • Fraefel, C.1    Song, S.2    Lim, F.3    Lang, P.4    Yu, L.5    Wang, Y.6    Wild, P.7    Geller, A.I.8
  • 64
    • 0036094421 scopus 로고    scopus 로고
    • Expression of human immunodeficiency virus type 1 gp120 from herpes simplex virus type 1-derived amplicons results in potent, specific, and durable cellular and humoral immune responses
    • Hocknell PK, Wiley RD, Wang X, Evans TG, Bowers WJ, Hanke T, Federoff HJ, Dewhurst S (2002) Expression of human immunodeficiency virus type 1 gp120 from herpes simplex virus type 1-derived amplicons results in potent, specific, and durable cellular and humoral immune responses. J Virol 76:5565-5580
    • (2002) J Virol , vol.76 , pp. 5565-5580
    • Hocknell, P.K.1    Wiley, R.D.2    Wang, X.3    Evans, T.G.4    Bowers, W.J.5    Hanke, T.6    Federoff, H.J.7    Dewhurst, S.8
  • 65
    • 34748832388 scopus 로고    scopus 로고
    • HSV-1 amplicon vectors elicit polyfunctional T cell responses to HIV-1 Env, and strongly boost responses to an adenovirus prime
    • Duke CM, Maguire CA, Keefer MC, Federoff HJ, Bowers WJ, Dewhurst S (2007) HSV-1 amplicon vectors elicit polyfunctional T cell responses to HIV-1 Env, and strongly boost responses to an adenovirus prime. Vaccine 25:7410-7421
    • (2007) Vaccine , vol.25 , pp. 7410-7421
    • Duke, C.M.1    Maguire, C.A.2    Keefer, M.C.3    Federoff, H.J.4    Bowers, W.J.5    Dewhurst, S.6
  • 66
    • 57349146688 scopus 로고    scopus 로고
    • Herpes simplex virus ICP0 promotes both histone removal and acetylation on viral DNA during lytic infection
    • Cliffe AR, Knipe DM (2008) Herpes simplex virus ICP0 promotes both histone removal and acetylation on viral DNA during lytic infection. J Virol 82:12030-12038
    • (2008) J Virol , vol.82 , pp. 12030-12038
    • Cliffe, A.R.1    Knipe, D.M.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.